Delivery Order SPE2DB20D2104-SPE2DB24FU78H

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,402.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REPATHA 140 MG/ML SURECLICK syringes, with an ultimate completion date of April 9, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,714.99, is a firm-fixed-price delivery order for the supply of REPATHA 140 MG/ML SURECLICK ML, a medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,103.96, is a delivery order for the medical product "REPATHA 140 MG/ML SURECLICK." The contract has an ultimate completion date of April 3, 2025 and is a firm fixed-price contract. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This is a $1,381.95 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, with a period of performance through April 15, 2025. The contract is a firm-fixed-price arrangement and was not set aside for any specific business category. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This federal contract award, with ID SPE2DX15D1205|SPE2DX23F56P9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,768.80 firm fixed-price delivery order is for the supply of REPATHA 140 MG/ML SURECLICK medication. The contract has an ultimate completion date of April 20, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,111.53 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a cardiovascular medication, with a completion date of May 17, 2023. This award is a discrete delivery order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,155.94 contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025 and does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant...
This is a $2,527.18 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REPATHA 140 MG/ML SURECLICK, a pharmaceutical product, with a performance period through May 19, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,444.87, is for the provision of REPATHA 140 MG/ML SURECLICK medication. This is a Firm Fixed Price Delivery Order contract with a completion date of June 24, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,273.36 firm fixed-price delivery order is for the supply of REPATHA 140 MG/ML SURECLICK, a specialty medication. The contract has an ultimate completion date of May 11, 2023 and was awarded on May 10, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU78H
    Delivery Order

This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,016.82, is a delivery order for the product "REPATHA 140 MG/ML SURECLICK ML" and has a completion date of June 21, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 11:30 AM